666 related articles for article (PubMed ID: 35646540)
1. Bile acid coordinates microbiota homeostasis and systemic immunometabolism in cardiometabolic diseases.
Guan B; Tong J; Hao H; Yang Z; Chen K; Xu H; Wang A
Acta Pharm Sin B; 2022 May; 12(5):2129-2149. PubMed ID: 35646540
[TBL] [Abstract][Full Text] [Related]
2. Bile acids contribute to the development of non-alcoholic steatohepatitis in mice.
Gillard J; Clerbaux LA; Nachit M; Sempoux C; Staels B; Bindels LB; Tailleux A; Leclercq IA
JHEP Rep; 2022 Jan; 4(1):100387. PubMed ID: 34825156
[TBL] [Abstract][Full Text] [Related]
3. Bile acid nuclear receptor FXR and digestive system diseases.
Ding L; Yang L; Wang Z; Huang W
Acta Pharm Sin B; 2015 Mar; 5(2):135-44. PubMed ID: 26579439
[TBL] [Abstract][Full Text] [Related]
4. Bile acids are nutrient signaling hormones.
Zhou H; Hylemon PB
Steroids; 2014 Aug; 86():62-8. PubMed ID: 24819989
[TBL] [Abstract][Full Text] [Related]
5. A Current Understanding of Bile Acids in Chronic Liver Disease.
Farooqui N; Elhence A; Shalimar
J Clin Exp Hepatol; 2022; 12(1):155-173. PubMed ID: 35068796
[TBL] [Abstract][Full Text] [Related]
6. Bile acids and sphingosine-1-phosphate receptor 2 in hepatic lipid metabolism.
Kwong E; Li Y; Hylemon PB; Zhou H
Acta Pharm Sin B; 2015 Mar; 5(2):151-7. PubMed ID: 26579441
[TBL] [Abstract][Full Text] [Related]
7. Farnesoid X receptor, the bile acid sensing nuclear receptor, in liver regeneration.
Li G; L Guo G
Acta Pharm Sin B; 2015 Mar; 5(2):93-8. PubMed ID: 26579433
[TBL] [Abstract][Full Text] [Related]
8. The influences of cholecystectomy on the circadian rhythms of bile acids as well as the enterohepatic transporters and enzymes systems in mice.
Zhang F; Duan Y; Xi L; Wei M; Shi A; Zhou Y; Wei Y; Wu X
Chronobiol Int; 2018 May; 35(5):673-690. PubMed ID: 29381405
[TBL] [Abstract][Full Text] [Related]
9. Role of farnesoid X receptor and bile acids in alcoholic liver disease.
Manley S; Ding W
Acta Pharm Sin B; 2015 Mar; 5(2):158-67. PubMed ID: 26579442
[TBL] [Abstract][Full Text] [Related]
10. Increased bile acids in enterohepatic circulation by short-term calorie restriction in male mice.
Fu ZD; Klaassen CD
Toxicol Appl Pharmacol; 2013 Dec; 273(3):680-90. PubMed ID: 24183703
[TBL] [Abstract][Full Text] [Related]
11. Hyperoside attenuates non-alcoholic fatty liver disease in rats via cholesterol metabolism and bile acid metabolism.
Wang S; Sheng F; Zou L; Xiao J; Li P
J Adv Res; 2021 Dec; 34():109-122. PubMed ID: 35024184
[TBL] [Abstract][Full Text] [Related]
12. Ablation of gut microbiota alleviates obesity-induced hepatic steatosis and glucose intolerance by modulating bile acid metabolism in hamsters.
Sun L; Pang Y; Wang X; Wu Q; Liu H; Liu B; Liu G; Ye M; Kong W; Jiang C
Acta Pharm Sin B; 2019 Jul; 9(4):702-710. PubMed ID: 31384531
[TBL] [Abstract][Full Text] [Related]
13. Understanding the physiological functions of the host xenobiotic-sensing nuclear receptors PXR and CAR on the gut microbiome using genetically modified mice.
Little M; Dutta M; Li H; Matson A; Shi X; Mascarinas G; Molla B; Weigel K; Gu H; Mani S; Cui JY
Acta Pharm Sin B; 2022 Feb; 12(2):801-820. PubMed ID: 35256948
[TBL] [Abstract][Full Text] [Related]
14. Pegbelfermin selectively reduces secondary bile acid concentrations in patients with non-alcoholic steatohepatitis.
Luo Y; Decato BE; Charles ED; Shevell DE; McNaney C; Shipkova P; Apfel A; Tirucherai GS; Sanyal AJ
JHEP Rep; 2022 Jan; 4(1):100392. PubMed ID: 34977519
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic regulation of autophagy in hepatic metabolism.
Byrnes K; Blessinger S; Bailey NT; Scaife R; Liu G; Khambu B
Acta Pharm Sin B; 2022 Jan; 12(1):33-49. PubMed ID: 35127371
[TBL] [Abstract][Full Text] [Related]
16. The ménage à trois of autophagy, lipid droplets and liver disease.
Filali-Mouncef Y; Hunter C; Roccio F; Zagkou S; Dupont N; Primard C; Proikas-Cezanne T; Reggiori F
Autophagy; 2022 Jan; 18(1):50-72. PubMed ID: 33794741
[TBL] [Abstract][Full Text] [Related]
17. Individual bile acids have differential effects on bile acid signaling in mice.
Song P; Rockwell CE; Cui JY; Klaassen CD
Toxicol Appl Pharmacol; 2015 Feb; 283(1):57-64. PubMed ID: 25582706
[TBL] [Abstract][Full Text] [Related]
18. Metabolic effects of intestinal absorption and enterohepatic cycling of bile acids.
Ferrebee CB; Dawson PA
Acta Pharm Sin B; 2015 Mar; 5(2):129-34. PubMed ID: 26579438
[TBL] [Abstract][Full Text] [Related]
19. Potency of individual bile acids to regulate bile acid synthesis and transport genes in primary human hepatocyte cultures.
Liu J; Lu H; Lu YF; Lei X; Cui JY; Ellis E; Strom SC; Klaassen CD
Toxicol Sci; 2014 Oct; 141(2):538-46. PubMed ID: 25055961
[TBL] [Abstract][Full Text] [Related]
20. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]